Tacalyx
PrivateLast Round
Seed
Apr 29, 2026
Total Funding Raised
$28M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tacalyx is a biotechnology company that develops novel anticancer therapeutics targeting Tumor Associated Carbohydrate Antigens (TACAs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tacalyx Comparables
Compare Tacalyx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GO Therapeutics | 86% | |
| 遠友ファーマ株式会社 | 84% | |
| TegMine Therapeutics | 81% |
Tacalyx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 29, 2026 | ||||
| Seed | Jun 11, 2024 | ||||
| Seed | Sep 25, 2019 |
Key People
Founding team and executive leadership
Tacalyx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Seed |
| Idinvest Partners | Seed |
| Eurazeo Investment Manager | Seed |
| Thuja Capital | Seed |
| Max Planck Society for the Advancement of Science | Seed |
| Boehringer Ingelheim Venture Fund | Seed |
| Creathor Venture | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 6960% MoM, from 10 to 706.
- Apr 29, 2026
$12M round with participation from Eurazeo and Boehringer Ingelheim.
Tacalyx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tacalyx's valuation, stock price, and market status.
Is Tacalyx a public or private company?
Tacalyx is a private company.
What is the current stock price of Tacalyx?
Tacalyx is a private company with no public stock price. No recent secondary market data is available.
How much is Tacalyx worth (valuation)?
Valuation information for Tacalyx is not publicly available.
Can I buy Tacalyx stock?
Tacalyx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tacalyx's last funding round?
Tacalyx's most recent funding round was Seed on April 29, 2026.
Who are the main investors in Tacalyx?
Key investors in Tacalyx include Boehringer Ingelheim, Thuja Capital, Kurma Partners.
Will Tacalyx IPO soon?
No public IPO plans have been announced for Tacalyx.
How can I track Tacalyx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tacalyx's secondary market activity and sign up for updates.